Medications for Acute Lymphocytic Leukemia
Other names:
Acute childhood leukemia; ALL Leukemia; Cancer, Acute Childhood Leukemia; Cancer, Acute Lymphocytic Leukemia; Leukemia, Acute Childhood; Leukemia, Acute Lymphocytic
What is Acute Lymphocytic Leukemia:
Acute lymphocytic leukemia is a progressive, malignant disease characterized by large numbers of immature white blood cells that resemble lymphoblasts. These cells can be found in the blood, the bone marrow, the lymph nodes, the spleen, and other organs.
Medications to treat Acute Lymphocytic Leukemia
The following list of medications are in some way related to, or
used in the treatment of this condition.
|
Drug name
|
Rx / OTC
|
Preg
|
CSA
|
Alcohol |
Reviews
|
Rating
|
Popularity
|
|
prednisone
|
Rx
|
C
|
N
|
|
Add review
|
Add
|
|
|
Generic name: prednisone systemic
Drug class:
glucocorticoids
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
|
| |
|
Cytoxan
|
Rx
|
D
|
N
|
|
Add review
|
Add
|
|
|
Generic name: cyclophosphamide systemic
Drug class:
alkylating agents
For consumers:
dosage,
interactions,
side effects
For professionals:
AHFS DI Monograph,
Prescribing Information
|
| |
|
vincristine
|
Rx
|
D
|
N
|
|
Add review
|
Add
|
|
|
Generic name: vincristine systemic
Brand names:
Oncovin,
Vincasar PFS
Drug class:
mitotic inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
|
| |
|
cyclophosphamide
|
Rx
|
D
|
N
|
|
Add review
|
Add
|
|
|
Generic name: cyclophosphamide systemic
Brand names:
Cytoxan,
Neosar,
Cytoxan Lyophilized
Drug class:
alkylating agents
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
|
| |
|
asparaginase escherichia coli
|
Rx
|
C
|
N
|
|
Add review
|
Add
|
|
|
Generic name: asparaginase escherichia coli systemic
Brand name:
Elspar
Drug class:
miscellaneous antineoplastics
For consumers:
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph
|
| |
|
methotrexate
|
Rx
|
X
|
N
|
X
|
Add review
|
Add
|
|
|
Generic name: methotrexate systemic
Brand name:
Trexall
Drug class:
antimetabolites,
antirheumatics,
antipsoriatics,
other immunosuppressants
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
|
| |
|
Oncovin
|
Rx
|
D
|
N
|
|
Add review
|
Add
|
|
|
Generic name: vincristine systemic
Drug class:
mitotic inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
AHFS DI Monograph
|
| |
|
Trexall
|
Rx
|
X
|
N
|
X
|
Add review
|
Add
|
|
|
Generic name: methotrexate systemic
Drug class:
antimetabolites,
antirheumatics,
antipsoriatics,
other immunosuppressants
For consumers:
dosage,
interactions,
side effects
For professionals:
Prescribing Information
|
| |
|
daunorubicin
|
Rx
|
D
|
N
|
|
Add review
|
Add
|
|
|
Generic name: daunorubicin systemic
Brand name:
Cerubidine
Drug class:
antibiotics/antineoplastics
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
|
| |
|
Elspar
|
Rx
|
C
|
N
|
|
Add review
|
Add
|
|
|
Generic name: asparaginase escherichia coli systemic
Drug class:
miscellaneous antineoplastics
For consumers:
dosage,
interactions,
side effects
For professionals:
AHFS DI Monograph,
Prescribing Information
|
| |
|
Vincasar PFS
|
Rx
|
D
|
N
|
|
Add review
|
Add
|
|
|
Generic name: vincristine systemic
Drug class:
mitotic inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
Prescribing Information
|
| |
|
Erwinaze
|
Rx
|
C
|
N
|
|
Add review
|
Add
|
|
|
Generic name: asparaginase erwinia chrysanthemi systemic
Drug class:
miscellaneous antineoplastics
For consumers:
dosage,
interactions,
side effects
For professionals:
AHFS DI Monograph,
Prescribing Information
|
| |
|
Cerubidine
|
Rx
|
D
|
N
|
|
Add review
|
Add
|
|
|
Generic name: daunorubicin systemic
Drug class:
antibiotics/antineoplastics
For consumers:
dosage,
interactions,
side effects
For professionals:
Prescribing Information
|
| |
|
asparaginase erwinia chrysanthemi
|
Rx
|
C
|
N
|
|
Add review
|
Add
|
|
|
Generic name: asparaginase erwinia chrysanthemi systemic
Brand name:
Erwinaze
Drug class:
miscellaneous antineoplastics
For consumers:
dosage,
interactions,
side effects
For professionals:
AHFS DI Monograph
|
| |
|
Vumon
|
Rx
|
D
|
N
|
|
Add review
|
Add
|
|
|
Generic name: teniposide systemic
Drug class:
mitotic inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
AHFS DI Monograph,
Prescribing Information
|
| |
|
Neosar
|
Rx
|
D
|
N
|
|
Add review
|
Add
|
|
|
Generic name: cyclophosphamide systemic
Drug class:
alkylating agents
For consumers:
dosage,
interactions,
side effects
|
| |
|
Cytoxan Lyophilized
|
Rx
|
D
|
N
|
|
Add review
|
Add
|
|
|
Generic name: cyclophosphamide systemic
Drug class:
alkylating agents
For consumers:
dosage,
interactions,
side effects
|
| |
|
teniposide
|
Rx
|
D
|
N
|
|
Add review
|
Add
|
|
|
Generic name: teniposide systemic
Brand name:
Vumon
Drug class:
mitotic inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
|
| |
Learn more about Acute Lymphocytic Leukemia
Micromedex® Care Notes
Symptoms and treatments
Mayo Clinic Reference
Legend
| Off Label |
This medication may not be approved by the FDA for the treatment of this condition. |
| Prescription Only / Over the Counter |
| Rx |
Prescription Only |
| OTC |
Over the Counter |
| Rx/OTC |
Prescription or Over the Counter |
| Pregnancy |
| A |
Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
| B |
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
| C |
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| D |
There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| X |
Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. |
| N |
FDA has not classified the drug. |
| Controlled Substances Act Schedule |
| N |
Is not subject to the Controlled Substances Act. |
| 1 |
Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. |
| 2 |
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
| 3 |
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 |
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
| 5 |
Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
| Alcohol |
| X |
Interacts with Alcohol. |
Browse Drugs by Condition